VivoSim Labs, Inc. Effective Income Tax Rate Reconciliation, Tax Credit, Percent
VivoSim Labs, Inc. (VIVS) reported Effective Income Tax Rate Reconciliation, Tax Credit, Percent of -1.30% for the 12-month period ending 2026-03-31, per its 10-K filed 2026-07-14.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits · last filed 2026-07-14
- VivoSim Labs, Inc. effective income tax rate reconciliation, tax credit, percent for fiscal 2026 was -1.30%.
- VivoSim Labs, Inc. effective income tax rate reconciliation, tax credit, percent for fiscal 2025 was -12.90%.
| Period end | Effective Income Tax Rate Reconciliation, Tax Credit, Percent 12 month |
|---|---|
| 2026-03-31 | -1.30% 10-K · filed 2026-07-14 |
| 2025-03-31 | -12.90% 10-K · filed 2026-07-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |